JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (1): 22-28.doi: 10.6040/j.issn.1671-7554.0.2015.303

Previous Articles     Next Articles

Preparation and pharmacokinetics of baicalin lipid nanocapsules

MU Jun1,2, SHAN Lina3, ZHAI Yingjie2, ZHAI Guangxi2   

  1. 1. Department of Pharmacy, Shengbei Hospital, Shengli Petroleum Administrative Bureau, Dongying 257064, Shandong, China;
    2. Department of Pharmaceutics, College of Pharmaceutical Science, Shangdong University, Jinan 250012, Shandong, China;
    3. Department of Traditional Chinese Medicine, Shengbei Hospital, Shengli Petroleum Administrative Bureau, Dongying 257064, Shandong, China
  • Received:2015-03-20 Online:2016-01-11 Published:2016-01-11

PDF (PC)

364

Abstract: Objective To prepare the novel baicalin-lipid nanocapsules(BA-LNC)and to detect the physical and chemical properties and the pharmacokinetics. Methods With the medium chain triglyceride(MCT)as oil phase,polyethylene glycol monostearate as surface active agent, lecithin as auxiliary emulsifier, lipid nanocapsules(LNC)were prepared by the phase inversion method and evaluated with encapsulation efficiency(EE)and drug loading(DL). The formulation was optimized by the simplex lattice method and the optimal prescription was obtained by a response surface method. The pharmacokinetic study was also conducted in Wistar rats to explore the potential of LNC as carriers of baicalin. Results The EE was 92.58% and the DL was 1.69%. Under the transmission electron microscope, BA-LNC was spherical without adhesion. The average particle size was(84.2±1.7)nm with the polydispersity index being 0.201, and the Zeta potential was(-13.2±0.62)mV. BA-LNC could significantly prolong the residence time of drug in vivo, and obviously improve the oral absorption of baicalin. Conclusion The prepared lipid nanocapsules can obviously increase the oral bioavailability of baicalin.

Key words: Baicalin, Phase inversion-based method, Simplex lattice, Lipid nanocapsules

CLC Number: 

  • R944.1
[1] Sakurama H, Kishino S, Uchibori Y, et al. β-Glucuronidase from Lactobacillus brevis useful for baicalin hydrolysis belongs to glycoside hydrolase family 30[J]. Appl Microbiol Biotechnol, 2014, 98(9): 4021-4032.
[2] Andrae-Marobela K, Ghislain FW, Okatch H, et al. Polyphenols: a diverse class of multi-target anti-HIV-1 agents[J]. Curr Drug Metab, 2013, 14(4): 392-413.
[3] Lee B, Sur B, Shim I, et al. Baicalin improves chronic corticosterone-induced learning and memory deficits via the enhancement of impaired hippocampal brain-derived neurotrophic factor and cAMP response element-binding protein expression in the rat[J]. J Nat Med, 2014, 68(1): 132-143.
[4] Liu XB, Gu JM, Fan YQ, et al. Baicalin attenuates acute myocardial infarction of rats via mediating the mitogen-activated protein kinase pathway[J]. Biol Pharm Bull, 2013, 36(6): 988-994.
[5] Farris P, Yatskayer M, Chen N, et al. Evaluation of efficacy and tolerance of a nighttime topical antioxidant containing resveratrol, baicalin, and vitamin E for treatment of mild to moderately photodamaged skin[J]. J Drugs Dermatol, 2014, 13(12): 1467-1472.
[6] Xu MJ, Chen XM, Gu Y, et al. Baicalin can scavenge peroxynitrite and ameliorate endogenous peroxynitrite-mediated neurotoxicity in cerebral ischemia-reperfusion injury[J]. J Ethnopharmacol, 2013, 150(1): 116-124.
[7] 何琳,丁沐淦,卢秀霞,等. 黄芩苷在不同 pH 值缓冲液中理化常数的测定[J]. 西北药学杂志, 2012, 27(3): 208-211. HE Lin, DING Mugan, LU Xiuxia, et al. Physicochemical properties of baicalin in different pH phosphate buffer solutions[J]. Northwest Pharmaceutical Journal, 2012, 27(3): 208-211.
[8] Lu CM, Lin LC, Tsai TH. Determination and pharmacokinetic study of gentiopicroside, geniposide, baicalin, and swertiamarin in chinese herbal formulae after oral administration in rats by LC-MS/MS[J]. Molecules, 2014, 19(12): 21560-21578.
[9] Zhao L, Wei Y, Huang Y, et al. Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation[J]. Int J Nanomedicine, 2013, 8: 3769-3779.
[10] 靳世英,袁海龙,靳士晓,等.黄芩苷纳米晶体微丸的制备及其药代动力学初步研究[J].中国中药杂志, 2013, 38(8): 1156-1159. JIN Shiying, YUAN Hailong, JIN Shixiao, et al. Preparation of baicalin nanocrystal pellets and preliminary study on its pharmacokinetics[J]. 2013, 38(8): 1156-1159.
[11] Heurtault B, Saulnier P, Pech B, et al. A novel phase inversion-based process for the preparation of lipid nanocarriers[J]. Pharm Res, 2002, 19(6): 875-880.
[12] 王超,翟光喜.芹黄素类脂纳米囊的制备与理化性质考察[J].食品与药品, 2012, 14(1): 21-25. WANG Chao, ZHAI Guangxi. Preparation and characterization of apigenin-loaded lipid nanocapsules[J]. Food and Drug, 2012, 14(1): 21-25.
[13] Binkhathlan Z, Lavasanifar A. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives[J]. Curr Cancer Drug Targets, 2013, 13(3): 326-346.
[14] Desai PP, Date AA, Patravale VB. Overcoming poor oral bioavailability using nanoparticle formulations-opportunities and limitations[J]. Drug Discov Today Technol, 2012, 9(2): e87-e95.
[15] Parejiya PB, Patel RC, Mehta DM, et al. Quick dissolving films of nebivolol hydrochloride: formulation and optimization by a simplex lattice design[J]. J Clin Invest, 2013, 43(4): 343-351.
[16] Perrier T, Saulnier P, Fouchet F, et al. Post-insertion into lipid nanocapsules(LNCs): from experimental aspects to mechanisms[J]. Int J Pharm, 2010, 396(1-2): 204-209.
[17] Zhai YJ, Liu MR, Wan M, et al. Preparation and characterization of puerarin-Loaded lipid nanocapsules[J]. J Nanosci Nanotechno, 2015, 15(4): 2643-2649.
[18] Wu HY, Long XY, Yuan F, et al. Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin[J]. Acta Pharm Sinica, 2014, 4(3): 217-226.
[19] Lu T, Song J, Huang F, et al. Comparative pharmacokinetics of baicalin after oral administration of pure baicalin, radix scutellariae extract and huang-lian-jie-du-tang to rats[J]. J Ethnopharmacol, 2007, 110(3): 412-418.
[20] He MY, Deng YX, Shi QZ, et al. Comparative pharmacokinetic investigation on baicalin and wogonoside in type 2 diabetic and normal rats after oral administration of traditional chinese medicine Huanglian Jiedu decoction[J]. J Ethnopharmacol, 2014, 155(1): 334-342.
[1] YU Xin, LIU Xiaojing, LIU Xiangqun. The inhibitory effect of baicalin on endothelial cell apoptosis induced by ox-LDL [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(5): 5-9.
[2] YIN Hai-peng， LIU Xiang-qun, YU Xin, WANG Min. Effect of Baicalin on atherosclerosis ApoE-/- mice and VE-cadherin level [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 26-30.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd